NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

download NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

of 18

Transcript of NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    1/46

     

    Patient-Reported Outcomes in Performance Measurement

    Commissioned Paper onPRO-Based Performance Measures for Healthcare Accountable Entities

    October 22, 2012

    Prepared for NQF

     Anne Deutsch, RN, PhD, CRRN;1 Laura Smith, PhD;1 Barbara Gage, PhD;2

    Cynthia Kelleher, MPH, MBA;1 Danielle Garfinkel, BA

    1RTI International, 2Brookings Institution

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    2/46

     

    "

    Introduction

    National Quality Forum Initiative

    #$% &'()*+', -.',)(/ 0*1.2 3&-04 )5 %26'17)+8 *+ '+ %99*1( (* %:'2)+% ($%

    2%($*;*,*8)%19*12'+'()%+(?1%>*1(%; *.(1*E%1*>*1( ($)5 )+)()'()=%H &-0 '>%15 *+ ($% .5% *9 @AB5 )+

    >%19*12'+%1 1%=)%I%; ($% )+5(1.2%+(?,%=%, )55.%5 ($'( 5$*.,; 6%

    %1H ($% 5% )+9*12 +%:( 5(%>5 *+ ($%

    >'($ (* ;%=%,*>)+8 @AB?@F5 6/ %:'2)+)+8 2%($*;*,*8)%19*12'+%19*12'+*1( *+ ($% %:>%1)%+%15 ';;1%55 ($%5% >1*6,%25O ($)5 >'>%1 8*%5

    6%/*+; 2%'5.1%2%+( *9 )+;)=);.', >'()%+( *.(%1 %:'2)+%5 5*2% 7%/

    2%($*;*,*8)2%+(

    3%C8CH )55.%5 *9 1%,)'6),)(/ '+; =',);)(/4H '5 ;)5'>%1CJ P$%+ '881%8'()+8 @ABF

    1%5>*+5%5 '1*=);%1 *18'+)K'()*+C 0.1($%1H ($% '>>1*'.,'()*+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    3/46

     

    R

    #$% 5%,%1)*1)()%5 9*1 >%19*12'+%1C #$% )2>*1('+%19*12'+*)+(H 9*1 ($)5 >'>%1H )5 ($'( &-0 1%=)%I5 '+; %+;*15%5 >%19*12'+')+H ;%>1%55)*+H 9.+%1 '5 ($%/ '1% .5%; 6/ &-0 )+ ($)5 )+)()'()=%U

    !"#$%'(%)*(#%+ *-#.*/% 0!123U #$% '()%+(D5 1%5>*+5% 6/ ' %1'()%+(H *6(')+%; 6/

    ;)1%*1( 3%C8CH @W-?X4C

    !%(9*(/"&.% /%"6-(%U &.2%1)< G.'+()9)1*;.

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    4/46

     

    [

    Key Components of a Performance Measure

    Y+ *18'+)K'()*+', >%19*12'+%1H ]%,,' %( ',C );%+()9)%; ($% 9*,,*I)+8 %)8$( )2>*1('+(

    1*;.(.1%4C

    d''()%+( ,%=%,C 0*1 %:'2>,%H >')+ '+; ;%>1%55)*+ 5/2>(*25 '1% )2>*1('+( $%',($

    )55.%5 (* 2%'5.1% '5 ' @ABH 6.( '()%+(5 I$* '1% .+'6,% (* 5%,9?1%>*1( ($%)1 >')+ 5('(.5 *1

    ;%>1%55)=% 5/2>(*25H ;'(' '()%+( *65%1='()*+ 2'/ +*( 6%

    %G.)=',%+( (* ($% >'()%+(5D 5%,9?1%>*1(C #$%1%9*1%H 1%G.)1)+8 ($% .5% *9 ',(%1+'()=% 5*.11)'(% I)($)+ ' @ABF?@FC Q)2),'1,/H %:>%1)%+%1()*+5 *1 1%>*1(5 '6*.( '

    '()%+(D5 %,%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    5/46

     

    `

    3dWA54H 6%*>.,'()*+

      )+(%1>1%('6),)(/ *9 5%19*12'+>1*>1)'(%4\)5

    '='),'6,%H ($% @AB?@F 2'/ 6% 2*1% 1*6.5( ($'+ ',(%1+'()=%5 .+;%1 *>.,'()*+C Q*2% @ABF5 '1% >,/ (* ' I);% 1'+8% *9

    )+;)=);.',5H )+,%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    6/46

     

    a

    5>%*>.,'()*+C[ 0*1 5*2%

    >*>.,'()*+5H 1*=);% )+9*12'()*+ ($'( )5 ;)1%*>.,'()*+ '+; %:*1('+%19*12'+%1H ($% +%:( 5%'>%1 ;%5()*+5 9*1 '()%+(?,%=%, @ABF ;'(' )+(* ' >1*=);%1?,%=%,

    @AB?@FC #$% '>>1*''()%+( >*>.,'()*+C #$%*.('()%+(?1%>*1(%; *.(

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    7/46

     

    b

    >*5)()=% '+; +%8'()=% %19*12'+%19*12'+')+ 35$*1( 5('/4M 3&-0 g eaba4 .5%5 ' >*)+(?)+?()2% ($1%5$*,; =',.%C #$%

    >%19*12'+1%55)*+H (* '

    9*,,*I?.> .> 5>1*'%+;5 *+ ($% 2%'5.1%2%+( 8*',C

    #$% >%19*12'+**1

    G.',)(/ '+; )5 ;%1)=%; 91*2 ($% )+;)=);.',?,%=%, @ABF ;'('C 0*1 ' @AB?@F 5*>.,'()*+CJb

     

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    8/46

     

    c

    Y+ ',(%1+'()=% (* 1%>*1()+8 ' 2%'+ )5 (* '()%+(5 I$* ''()%+( )5

    1%55)=% 5/2>(*25 %19*12'+%19*12'+%19*12'+*1()+8 >')+ 5'()%+( ;'/54C Y 1'()* 2'/ 6% >1%9%11%; '5 ($% >%19*12'+>1*>1)'(%C

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    9/46

     

    X

    d'% *9 @ABF 6%)+8 %:'2)+%;C Q%,%%+;5 *+ ($% (/>% *9 G.%5()*+ 6%)+8 '+5I%1%; '+; I$%($%1 ($% >1*>*5%; '>>1*'1*=);%5

    ' 1*6.5( 2%'5.1% 8)=%+ ($% %'('6),)(/ *1

    >1%1*=);%1 ,%=%, 1%9%15 (* ($% >1*>*1()*+ *9 ='1)'()*+ )+ ($% >%19*12'+*1()+8H >%1()*+5 *9 >1*=);%1

    G.',)(/H '+; >'/ 9*1 >%19*12'+>,/ ' 8%+%1',

    ,)%; '( %)($%1 ($% >'()%+( *1 >1*=);%1 ,%=%, '+;

    %19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    10/46

     

    Je

    (*(', ='1)'6),)(/ '2*+8 5.6E%1%(%; '5 ($% (1.% ;)99%1%+1*=);%15D @AB?@F 51*=);%15 6%)+8 %=',.'(%; 9*1 ($'( @AB?@FC

    #$)5 1%,)'6),)(/ 1*=);%15 )5 eCbeH '+; '2*+8 )+;)=);.', >1*=);%15 3%C8CH I$%+ '>'()%+( )5 5%,%%19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    11/46

     

    JJ

    @1*=);%1?,%=%, 1%,)'6),)(/ )5 ;%(%12)+%; 6/ ($1%% 9'1*=);%15H 3"4 ($% I)($)+?>1*=);%1 ='1)'()*+H '+; 3R4 ($% 5)K% *9 ($% >1*=);%1

    5'2>,% 3)C%CH ;%+*2)+'(*14CJX

     A%,)'6),)(/ )5 ($%1%9*1% +*( '+ )+(1)+5)< '()%+(5 )+1*=);%15H )9 2*5( >1*=);%15 >%19*12 I%,, *+ ' >'1()1*=);%1 ='1)'()*+4H @AB?@F 1%,)'6),)(/ 2'/ 6% ($1%'(%+%; 6%1*=);%1 @AB?@F5 2'/ ''()%+( >*>.,'()*+5 1'($%1 ($'+ (1.% ;)99%1%+1*=);%1 G.',)(/C m'5(,/H %5()2'(%5 9*1

    >1*=);%15 I)($ 9%I%1 >'()%+(5 *1 ,*I 1*=);%15 '+; ($%1%9*1% ,)7%,/ (* $'=% ,%55 5('6,% *1 ,%55 1%,)'6,% @AB?

    @F 51*%*>.,'()*+ ($'( ($% @AB?@F )5 ;%5)8+%; (* ,%H )9 ',, >1*=);%15 )2>1*=% ($%)1 (1.% >%19*12'+,% 2%($*;5 9*1 (%5()+8 1%,)'6),)(/ *9 ' >1*=);%1?,%=%, >%19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    12/46

     

    J"

    >1*>*1()*+CJXH ""

     W)%1'11*>1)'(% 9*1 *5)(%5 *1 %H .5)+8 $)%1'11*=);%1?5>%1*>*1()*+ *9 >1*=);%15

    9',, 6%,*I ' ($1%5$*,; *9 eCbeH 1%,)'6),)(/ 2'/ 6% ' 1*=);% ' 5.22'1/ 1%,)'6),)(/ 5 *9 1*'1*=);%5 ' 2%'+5 9*1 =)5.',,/ %:'2)+)+8 ($% %:(%+( *9 1'+;*2 %11*1 1%,'()=% (* ($% ;)99%1%+1*=);%1?,%=%, 5%19*12'+>1*>1)'(% 5('()5()>1*'%1%5%+(5 ' @AB?@F I)($

    ='1)'6),)(/ ($'( )5 %+()1%,/ '((1)6.('6,% (* (1.% ;)99%1%+1*=);%1 '+; ($% )+(1'?$%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    13/46

     

    JR

    ($% >1*=);%1 3*1 5.6E%*1('+( 9',% 5)K% +%%;%; (* >1*=);% ' 1%,)'6,% %5()2'(% '+; 3"4 ($% ,)7%,)$**; ($'( >1*=);%15 I),,

    ',% 5)K% 9*1 ' 5>%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    14/46

     

    J[

    1%,)'6,/ 9*1 )+;)=);.', %+;5 *+ ($% 1%', ;)99%1%+1*=);%15 '+; I)($)+?>1*=);%1 ='1)'()*+CJX

     Q)8+',?(*?+*)5% % '1)5*+5 '+; eCXe 9*1 )+;)=);.',

    '1)5*+54C d:'2)+)+8 ($% 1%,'()*+5$)> 6%(I%%+ )+;)=);.', >1*=);%15D 1%,)'6),)(/ %5()2'(%5

    '+; ($%)1 2%'5.1% ;%+*2)+'(*1 5)K%5 1*=);%15D >%19*12'+**1 *1 2'18)+', 1%,)'6),)(/ 3)C%CH ($%

    1%,)'6),)(/ )+;%:%5 ;%5%19*12'+1)'(%+%55 *9 >1*',% *1 2%'5.1% ;%+*2)+'(*1 5)K% 6/

    )+1*=);%15 ($'( I'+( (* 2'7% '>>1*>1)'(% 1*=)+8 ($% 1%,)'6),)(/ *9 ($% @ABF '( ($% )+;)=);.', ,%=%, '>%1J )+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    15/46

     

    J`

    @F 6'5%; *+ ($'( @ABFC A%,)'6),)(/ (%5()+8 1%5.,(5 1*=% ($% 1%,)'6),)(/ *9 ($% .+;%1,/)+8 @ABFC

    Y+*($%1 5(1'(%8/ 9*1 1%;.%19*12'+>,/ '

    1%,)'6),)(/ ';E.5(2%+(C #$)5 2%($*; 5$1)+75 @AB?@F %5()2'(%5 (*I'1; ($% 2%'+ =',.% 9*1

    >1*=);%15 )+ >1*>*1()*+ (* ($% '2*.+( *9 1'+;*2 %11*1 )+ ($% @AB?@F %5()2'(% 9*1 %'1*=);%1C #$%1%9*1% 9*1 52',,%1 >1*=);%15H I$)1*=);%1 )5 G.)(% >**1 '1%; I)($ ($% 2%'+H ($% 5$1)+7'8%

    %5()2'(% I),, 2'57 ($'( ;)99%1%+.,,)+8 ($% >1*=);%1 >%19*12'+*(%+()',,/ $'+;,%

    ($%5% '()%+( ';2)55)*+54C"J

     W*I%=%1H 8)=%+ ($% %=);%+%1(5 ;%6'(% ($% ;%5)1'6),)(/ *9 .5)+8

    >1*=);%1 5)K% 9*1 1%,)'6),)(/ ';E.5(2%+( )9 5)K% )5 6%)+8 2%'5.1%; '5 =*,.2% *9 >'()%+(5C

     R"

     Z*,.2% )5 ' >*(%+()',,/ %+;*8%+*.5 ='1)'6,% 6%*(%+()', %+;*8%+%)(/ ,%5

    *9 ($)5 2%($*; *9 .5)+8 5)K% '+; *($%1 >1*=);%1 '((1)6.(%5 9*1 1%,)'6),)(/ ';E.5(2%+(5 '>>,)%; (*

    >%19*12'+,%H ' 5(.;/ %:'2)+)+8 $*5>)(', 2*1(',)(/

    >%19*12'+%1

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    16/46

     

    Ja

    5* 2*1% 52',, $*5>)(',5 I%1% 2*=%; 91*2 ($% 6%5( >,)%;C"J

     

    V+ 5.22'1/H )( 2'/ +*( 6% >*55)6,% (* 8%( '+ '1*=%; @AB?@F %5()2'(%5 9*1 >1*=);%15 ($'( >1%=)*.5,/ 2'/ $'=% 6%%+ (** 52',,

    '+; .+5('6,% (* /)%,; 1%>*1('6,% 2%'5.1%5C #$)5 2%($*; )5 6%)+8 .5%; 9*1 >%19*12'+%19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    17/46

     

    Jb

    *9 ]'1;)*,*8/ '+; Y2%1)1%5%+( ($% >'()%+(D5 >%15>%%1(5M 6/ .5)+8 G.',)('()=% 1%5%'1*1('+( (* $'=%

    )+>.( 91*2 %:>%1(5 *.(5);% ($% 1%5%'11*=);%15D >%19*12'+%19*12'+%19*12'+,%H 9*1 5*2% @ABF5 ';;1%55)+8 ;%>1%55)*+ 5/2>(*25H

    )2>*1('+( 9%'(.1%5 '1% ($% +%%; (* '57 1%5>*+;%+(5 (* 1%9,%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    18/46

     

    Jc

    >%19*12'+1%55)*+ 2.5(

    (*25H

    5.%%19*12'+1)2'1/ (1%'(2%+( 8*', 9*1 (*2 ($'( )5 *9(%+ 2*+)(*1%; '%19*12'+')+ >,)%; (* ($% %+()1% >'()%+( >*>.,'()*+ 1*=);%1C 0*1 %:'2>,%H

    ($% >%19*12'+')+H I$)')+ *1 =%1/ 5%=%1%l$*11)6,% >')+ *9 '+/ 91%G.%+')+ 2%'5.1%2%+( )5 2*=)+8 91*2 .5)+8 ' +.2%1)')+ )+ ($% ]YAd )(%2 5%(

    3$((>UllIIIC>''()%+(5 )+ ($% ('18%( >*>.,'()*+ '()%+(5 I$* 52*7%C V9 *+,/ ' 52',, +.26%1 *9 >'()%+(5 I)($)+ '

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    19/46

     

    JX

    >1*=);%1 2%%( ($% %19*12'+%19*12'+*1('+(

    9*1 ' WA-m >%19*12'+.,'()*+5H

    5.%19*12'+'1()%19*12'+*1( )+(%1?)+(%1=)%I%1 1%,)'6),)(/C 0*1 ($% @AB?6'5%; >%19*12'+1%55)*+ A%2)55)*+

    I)($)+ a F*+($5M 3&-0 g ebJJ4H >'()%+(5 '1% 1%55%; 6'5%; *+ ($% )+)()', 5'()%+( 2'/ $'=% ' @W-?X 51%55%;C #$% >%19*12'+1%55)*+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    20/46

     

    "e

    5'()%+( (* 6% )+1%55%;H '1%

    +*( )+'()%+(5 I)($)+ ($% ('18%( >*>.,'()*+C @'()%+(5 91*2 ;)99%1%+( 6' ;)99%1%+'+)< P$)(%5CRX

     Y+*($%1 5(.;/H %:'2)+%; ($% 5%+5)()=)(/ '+; 5>%1%=)*.5,/ 5(.;)%; I)($ ($% @W-?XC[e r'+8[J 9*.+; ($'( I)($

    ($% ]%+(%1 9*1 d>);%2)*,*8)'1()()=% (%5()+8 )5 .5%; (* *+;%+(CA%5>*+;%+(5 I$* ;* +*( >1*=);% 1%5>*+5%5 )+ ($% %:>%'((%1+ 3;.% (* ;)99%1%+()', )(%2

    9.+,'

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    21/46

     

    "J

    Y+ *.(1%55)*+ 5/2>(*25C

    W*I%=%1H .5% *9 2*1% ($'+ *+% @ABF I*.,; 1%G.)1% 1%5%'1,%H )9 ($% >%19*12'+'()%+(5 )+(* 5 3%C8CH ;%>1%55%;H +*( ;%>1%55%;4H($% '1%9%1%+%19*12'+1*6,%25C

    Missing Data and Response Rates

    Y+*($%1 ($1%'( (* =',);)(/ *'()%+( 5.1=%/5C h.1)+8 ($% (%5()+8 *9 ' @AB?6'5%; >%19*12'+*1('+( (* 2*+)(*1 '+; 1%>*1(C Y 5.1=%/ I)($ ' ,*I 1%5>*+5% 1'(%

    ;.1)+8 (%5()+8 35*2%I$'( );%',

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    22/46

     

    ""

    >1'*+5% %11*1 )5

    ' %+;): YC

    Y5 >1%=)*.5,/ +*(%;H 1%5>*+5% 1'(%5 )+ ' *+5% 1'(%5 2'/ ='1/ 6/ >1*=);%1C

    T)=%+ ($'( >%19*12'+*1()+8 1%5>*+5% 1'(%5 ',*+8 I)($ >%19*12'+*+5% 1'(%5 '1% ,*IH 1%5.,(5 '1% 2*1% ,)7%,/ (* 6%

    6)'5%;H %)($%1 >*5)()=%,/ *1 +%8'()=%,/C[[?[a

     #$.5H 5.1=%/5 .5%; 9*1 @AB?@F5 5$*.,; );%',,/ 6%

    ;%=%,*>%; )+ ' I'/ ($'( *>()2)K%5 1%5>*+5% 1'(%5C 0*1 5%,9?1%>*1( 5.1=%/5H 5)2>,% 5(1'(%8)%5

    5.%11*=);)+8 '

    >$*+% +.26%1 9*1 G.%5()*+5H '5 I%,, '5 5**1('+(C #$% 1%5>*+;%+(5D >%1%15*+', )+9*12'()*+C #1.5( )5 '+*($%1 7%/ )55.% '+;

    1*=);%; 6/ ($% 1%5>*+;%+( '+%,5H .(H 1%?+*()9)'+)5$ 2'),)+85H ]$)+%5% (1'+5,'()*+5l,)9)%;

    ]$)+%5%H #1';)()*+', ]$)+%5%H A.55)'+H '+; Z)%(+'2%5%C

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    23/46

     

    "R

    F)55)+8 ;'('

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    24/46

     

    "[

    Threat to Validity: Inadequate on No Risk Adjustment

    Y+*($%1 >*(%+()', ($1%'( (* =',);)(/ 2)8$( 6% ;)99%1%+%15*+', '+; 1*')+)*+C V+9*12%; >'()%+(5 1*=);% =',.'6,% )+5)8$(5 )+(* >*(%+()', 9',%H ')+ 2)8$( 6% 5%=%1)(/ *9 '1($1)()5 *1 ()2% 5)+$)< 9' 5

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    25/46

     

    "`

    '+; 9*,,*I?.> 5 5'()%+(5 2'/ 1%>*1( 5.>%1)*1 9.+'()%+(5 I*.,; 6% %:>%5/'()%+( 9'%1 9*'1)()%5 F%'5.1%2%+(H

    P%)552'+ %( ',C 5.88%5( ' >1*'

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    26/46

     

    "a

    JC  Q(1'()9)>1*>1)'(% I$%+

    >%19*12'+%+;%+( *+ 1*=);%1D5 %19*12'+>*1( >**,)+8 ($%5% ;'('H %)($%1 I)($ *1 I)($*.( ';E.5(2%+(C V9 %=);%+>*1( >**,)+8 ($% ;'(' 6%'()%+(?,%=%, 51)+,%5 *9 6%5( >1'1*=);% 5.88%5(%; 6%5( >1'

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    27/46

     

    "b

    I*.,; 6% .5%;C #$% 1%81%55)*+ 1%5.,(5 I*.,; 6% '881%8'(%; )+(* ' 5.22'1/

    55 35(1'('4 .5)+8 ' +'()*+', ;)5(1)6.()*+ *1 *($%1

    5('+;'1;C 0*1 %*>.,'()*+ $'5 ' 1*1*=);%15

    $'=% ,%; 5*2% 2%'5.1% ;%=%,*>%15 (* .5% $)%1'11*=);%15 ($'( >1%=)*.5,/ 2'/ $'=% 6%%+ (** 52',, '+; .+5('6,% (* /)%,;

    1%>*1('6,% 2%'5.1%5C #$% WTmF '>>1*''>%1 LQ('()5()

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    28/46

     

    "c

    Q('()5(),%H )9 '+ .+;%5)1'6,% *.(%19*12'+%1')+ )5 1%>*1(%; I)($*.( ';E.5()+8 9*1

    >'()%+( *1 '()%+(54H '+; 5('+;'1; 1)57 ';E.5(2%+( 2%($*;5 2'/ +*(';%G.'(%,/ ';E.5( 9*1 ($%5% .+'()%+(5D 9'1*>%+5)(/ 51*6,%2H 1%9%11%; (* '5 5%,%.,'()*+ )5 +*( *>.,'()*+ )5

    )+'()%+(D5 =*).1>*5%5C

    Q)+'/?9*1?>%19*12'+1*81'25 '5 '+ )+'/2%+( >1*81'2C Y;;)()*+', I*17 )5 ($1%5$*,; 2%'5.1%5 3>%1*+5%5 )+;)

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    29/46

     

    "X

    )2>1*=%2%+(4C W*I%=%1H 2'+/ )55.%5 1%2')+ (* 6% ';;1%55%; ($'( ('7% )+(* ','*1(%; *+ ($% >.6,)< 1%>*1()+8 I%65)(%C #$% .5% *9 ($%

    ,'5( *+%+( )+ ($% *5)(% 2%'5.1% )5 5(),, 6%)+8 ;%=%,*>%;C

    F)++%5*(' ',5* 1%G.)1%; ($1*.8$ ,%8)5,'()*+ ($'( (I* (/>%5 *9 *1($*>%;)< 2%'5.1%5 6%

    )+% 5.18%1/C #$% 6'5%,)+% ;'(' 9*1 7+%% 1%>,''()%+(5 )5 )+% >'()%+( )5 '55%55%; 6%9*1% 5.18%1/ '+; J /%'1 '9(%1 5.18%1/C Q%,%*5(?

    5.18)>*)+(2%+(5O$*I%=%1H ($)5 )55.% I'5 %:(%+5)=%,/ ;)51%=%+('()=% ;%>1%55)*+ 2%'5.1%C #$)5 I),, 6% '

    >1*'()%+(H >'1%+(H '+; >1*:/ 1%5>*+5%5 '1%

    >'1()%;)'(1)< >*>.,'()*+5C

    B($%1 5('(%5 '1% ;%=%,*>)+8 5)2),'1 @AB?@F5 6.(H '5 +*(%; 6/ F)++%5*('D5 >1*81%55H

    2'+/ )55.%5 2.5( 6% %19*12'+*+%+()',,/ I)($ 2%'5.1%

    )2>,%2%+('()*+C #$% -.',)(/ Y,,)'+%'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    30/46

     

    Re

    England

    V+ "ee`H d+8,'+;D5 &'()*+', W%',($ Q%1=)'1(2%+( *9 W%',($ ),*( *99%1%; 5%=%1', =',.'6,% ,%55*+5 9*1 d+8,'+;D5 &'()*+', W%',($ Q%1=)'()%+(5 6% '57%; (* ,%(% ($% >1%?*>%1'()=%

    5.1=%/5 '( ($% ()2% *9 ';2)55)*+ 1'($%1 ($'+ ;.1)+8 ($% >1%?*>%1'()=% '55%552%+(C

      Q('99 (1')+)+8 I'5 1%%1),*( 5(.;/ I%1% )+%,)8)6,% (* ,%(% ($% 5.1=%/ ;.% (*

    '1()'(% ;.% (* =)5)*+ >1*6,%25C

      #$)1(%%+ >%1'()%+(5 ;%'1()'(%C

      0*1 >'()%+(5 I)($ *+5)=%+%55 '+;

    %1'()=% ;'('

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    31/46

     

    RJ

    '+; ='1)'()%+(5 .+;%18*)+8 *+% *9 ($%5% >1*5 6'5%; *+ ($% 9%'5)6),)(/ 5(.;/ ($'( 5$*I%; 1%?5.1=%/ '9(%1 ($%/ $'=% 6%%+ 2%;)%1'()=% G.%5()*++')1%5 '1% ($%+ 5%+( (* >'()%+(5 9*,,*I)+8 ($%)1 *>%1'()*+C #$% >*5(?*>%1'()=%

    5.1=%/ )5 5%+( *.( (* >'()%+(5 R 2*+($5 >*5(?5.18%1/ 9*1 $%1+)' '+; ='1) *1 7+%% 1%>,' 5.1=%/5 '1% ($%+

    ,)+7%; I)($ $*5>)(', %>)5*;% ;'('C N%(I%%+ Y>1), "eJe '+; F'1)(', %>)5*;%5H I)($ JbJH[XX 3aXCXi4 >1%?*>%1'()=% G.%5()*++')1%5 1%(.1+%;C V+

    1%5>*+5% (* ($% JbJH[XX >1%?*>%1'()=% G.%5()*++')1%5 1%(.1+%;H Ja"HaJ[ 3cJCei4 >*5(?

    *>%1'()=% G.%5()*++')1%5 I%1% 5%+( *.(H '+; JRJHaXa 3cJCei4 I%1% 1%(.1+%;C

    #$% W%',($ '+; Q*%19*12'+UllIIIC;$C8*=C.7l%[email protected],)*(%+()', 9*1 ' >'/2%+( )+%1)%+9., (* &-0D5 %99*1(5C Y 1%=)%I *9 ;'('?'1()'(% )+ ($% 5.1=%/C 0*1

    >'()%+(5 I$* %+;%+( ($)1; >'1(/ 1*=% 1%5>*+5% 1'(%5C

    P$%+ '881%8'()+8 ($% @ABF ;'(' (* ($% >1*=);%1 ,%=%,H '+',/5(5 )2>.(% 2)55)+8 ;'('

    91*2 5.1=%/ )(%25 6.( +*( 2)55)+8 5.1=%/5C d+8,'+; $'5 %:>,*1%; 5%=%1', *>()*+5 (* ;%', I)($

    ,*I 1%5>*+5% 1'(%5 )+1%? '+; >*5(?5.18%1/ G.%5()*++')1% (* 6% )+%19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    32/46

     

    R"

    #$% @ABF ;'(' '1% 1)57?';E.5(%; .5)+8 ($% T%+%1',)K%; m%'5( QG.'1%5 9):%; %99%%1'()=% @ABF 5'()%+( $'; '55)5('+1)*1 5.18%1/H 1*6,%2C h.% (* ($% $)8$ 1'(% *9 2)55)+8 ;'(' ';;)()*+', ''()%+(?,%=%, >1%;)*1('+( ;)99%1%+>1*:)2'(%,/ b` *9 ($%5% 1%8)5(1)%5

    )+1*=% *1(%; %:>%1)%+%15>%*1(%; ,)1*,'>5% 5.18%1/

      @'()%+(?1%>*1(%; *.(,'5(/

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    33/46

     

    RR

      @'()%+(?1%>*1(%; )2>1*=%2%+( '9(%1 )+)()'()*+ *9 6)*,*8)/ 9*1

    1$%.2'(*); '1($1)()5

      @'()%+(?1%>*1(%; )2>1*=%2%+( '9(%1 )+)()', *1(%; *.((*>,'5(/

    #$% 1%>*1( )+*+5% 1'(%5H '+; ;'(' '1% 5(1'()9)%; 6/ 2',% '+; 9%2',%C @ABF5

    ($'( $'=% %:)5(%; *=%1 ' ,*+8%1 >%1)*; '>>%'1 2*1% 1*6.5( )+ ($%)1 1%>*1()+8C Y+ %:'2>,% )5 ($%

    @ABF LQ'()59')(',CM #$% &'()*+', Q(1*7% A%8)5(1/ 2'),5 '

    G.%5()*++')1% (* ($% >'()%+( '+; 9'2),/ R 2*+($5 '9(%1 ($% >'()%+(D5 5(1*7%C P$),% ($% *=%1',,

    1%5>*+5% 1'(% 9*1 ($)5 2%'5.1% I'5

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    34/46

     

    R[

      V( +%%;5 (* ;%(%*+5% 1'(% (* @ABF5H '+; ($)5 )5 '((1)6.(%; )+ >'1( (*

    .+)G.% >'()%+( );%+()9)%15 ($'( ',,*I >'()%+(5 (* 6% (1'%+?'+;?>'>%1 ,)*5(?5.18%1/ 5.1=%/ 2'/ ',5* 6% )2>*1('+(C ]*22%+(5 )+ ($%

    QI%;)5$ W)> Y1($1*>,'5(/ A%8)5(%1/ 1%>*1( 5.88%5( ($'( d+8,'+;D5 '>>1*'%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    35/46

     

    R`

    ($%5% 5('+;'1;5 2.5( 6% )+*1'(%; )+(* ($% dWA (* ',,*I %,%%19*12'+%19*12'+%; 9*1 2*1% >1*'1*''()%+(?1%>*1(%; ;'(' 2'/ 6% 5.62)((%; )+ 5%=%1', I'/5H

    )+%15*+ =)5)(5H (%,%>$*+%?6'5%; 1%5>*+5%5H '+; %?2'), 1%5>*+5%5C p5)+8 ($% dWA '5

    ($% 5*.1'()%+(?1%>*1(%; )+9*12'()*+ 6% >1*''1*(*(.1% ($% >'()%+( 1%5>*+5%5C

    #$)5 )55.% %1 *1

    %,%>,)>*1(.+)()%5 9*1 ='1)'()*+5 )+ $*I >'()%+(5 '()%+(?1%>*1(%; ;'(' 2'/ +%%; (* 6% (1%'(%; '5 ),'+ *1 >1*=);%1 ,%=%,C #$%)1 .5% )+

    %,%

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    36/46

     

    Ra

    0.+'($ '1%'5 *1 )55.%5 *1('+( (* ($% >'()%+( *1 ($% %19*12'+,%H *+% *9 ($% '()%+( )+9.5)*+ >.2> ($%1'>/C #$)5 2%'5.1% )5 )+(%+;%; (*

    ';;1%55 ($% ReSa` >%1 *9 5*2% 5*1( ($'( '1% 1%,'(%; (*

    '+ ';=%15% %=%+(C N.( ';;)()*+', %15>% >%19*12'+ 5(1%+8($%+ ($%

    %F%'5.1% )+(%1>1%('()*+C F'+/ *9 &-0D5 );%+()9)%; $)8$?)2>'*1(%; *.(%;C

    #$% ($)1; '1%' 1')5%; 6/ ($% &-0 ';=)5*1/ 81*.> )5 )+8 '+ %F%'5.1% 9*1 @AB5C #* 5('1(H )( ;%',5 I)($ 7%/

    9'(.1% '+; 5.6E%%1,/ .(),)K%;

    '+; )+(%1>1%(%; 6/ ($% >'()%+( '+; .( 1*>1)'(% 5%(()+85C

    0*1 %:'2>,%H ' >'()%+(D5 8*', *9 1%(.1+)+8 $*2% 2'/ 6% >'1( *9 ' *5)(% 9*1 ' 57),,%; +.15)+8

    9'

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    37/46

     

    Rb

    V( )5 >%1()+%+( (* +*(% ($'( %F%'5.1% 5.%*>,% I$*

    1%>*1( ($'+ *+ ($% '(.1% 1%; 9,'85 5.99)*1('+( (* '.(*2'(% ' 2%'5.1%5/5(%2 (* );%+()9/ *.(,)%15H I% 2.5( *1(%; 9*1 ($% >.1>*5%5 *9

    )(5 .5%C 

    Conclusion

    #$% '1%' *9 @AB?@F5 )5 1%,'()=%,/ /*.+8 '+; 5(),, %=*,=)+8C Y,($*.8$ ($% >'()%+(D5 =*)*1('+'>%1 ;)51*=);%1 ,%=%,s

     –   W'5 )( 6%%+ (%5(%; (* %:'2)+% ($% 1'+;*2 %11*1 '55*()*+ *9 @ABF5H )+)()', 1%,)'6),)(/

    (%5()+8 I),, 6% ,)2)(%;C A%,)'6),)(/ 5(.;)%5 5$*.,; 6% >,'++%; (* )+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    38/46

     

    Rc

    *9 >1*=);%15 %'%% *9 %19*12'+*55)6,%C #* 2%%( 5('+;'1;5 *9 1*6.5(+%55H =',);)(/ 5(.;)%5

    +%%; ,% 5)K%5 ,'18% %+*.8$ (* (%5(C #$)5 2'/ +*( 6%

    >*55)6,% .+(), ' 2%'5.1% )5 )+ I);% .5%H I$))%19*12'+%1%9%1%+')+ ,%=%,5 31%,'()=% (* )+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    39/46

     

    RX

      ]*+5);%1'()*+5U A)57 ';E.5(2%+( )5 '+ )2>*1('+( 5(%> (* %+5.1% 9')1 '1)5*+5

    '1*=);%15C W*I%=%1H %19*12'+1%9%1%+%'1$%';%; 6/ ($%

    B99) ,'/ ($% 81*.+;I*17 9*1 )+*1'()+8

    ($%5% )(%25 )+(* ;'),/ (1%'(2%+(H I*179,*I >1*%%+;)+8 *+ I$%($%1 ($% @ABF I'5 '57)+8 ($% >'()%+(5 (* 1%>*1( *+ ''1()1*=);%5

    ($% 6%5( 2%'5.1% *9 I$%($%1 ($% >%15*+5 5%%7)+8 *1('+( )+ 2%'5.1)+8

    >%19*12'+

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    40/46

     

    [e

    F*=)+8 ($% >'()%+(D5 =*)

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    41/46

     

    [J

    References

    >?  ]%,,' hH W'$+ dYH t%+5%+ QdH N.(( oH &*I)+57) ]tH A*($1*/#*1(%; B.(>*1(m'6%,)+8 ],')25C"eeXC

    G?  Q(1%)+%1 hmH &*12'+ TAC =/"'#< 6/".*+/6/ .5"'/. 7 " :+"5#$5"' ?*$1/ #% #,')+ ($% ",% -'$&$5J Y>1

    "ee"Obb3[4URbJ?RcRC

    >>?  ]*,,)+5 mFH t*$+5(*+ FZC Y+',/5)5 *9 5('8%?5%G.%+()', B?  Q()+%2'+ FTH A*55 A&H 0)%;,%1 AH T1'+8%1 ]ZH F')5,)+ TC Q('8)+8 9.+>,)/1$5$&/ Q 9/()2', 8P -"&"1$"& >/1$5"' 8..%5$"#$%&

     P%*+&"'J "eJ"OJc[3R4UdJXJ?JXaC

    >G?  Y;'25 tmC L*1'()*+O"eeXC

    @H?  Y;'25 tmH F%$1*(1'H Y(%%=H F$.5'"..$2$5"#$%& $&

    3

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    42/46

     

    ["

    @>?  h)2))(',5 *+ 5.18)*1('+,'+ QWH T1)99)($ tmH @1)$/5)/1$5"' 5"+/J Y>1 "eeXO[b3[4URbc?RcbC

    @D?  W*9%1 #@H W'/I'1; AYH T1%%+9)%,; QH P'8+%1 dWH u'>,'+ QWH F'++)+8 PTC #$% .+1%,)'6),)(/ *9

    )+;)=);.', >$/5)8 7 #/1$5"' 8..%5$"#$%&J t.+ X JXXXO"cJ3""4U"eXc?"Je`C

    @E?  A*%61*%1*9),)+8U ' F*+(% ]'1,*

    '55%552%+(C P 0#"#$.# 3'"&& S&2/+/&5/J "ee`OJ"c3J4UJeX?J""C

    AH?  &'()*+', -.',)(/ 0*1.2C -%6:%.$#/ >/".*+/ B@"'*"#$%& T+"6/C%+M "&1 !"#$%&"' )%'*"+,

    -%&./&.*. 0#"&1"+1. 2%+ >%+#"'$#, "&1 0"2/#,U-%6:%.$#/ >/".*+/.7 8 -%&./&.*. 9/:%+#J J 

    P'5$)+8(*+H h]C"eeXC

    A>?  &*12'+; QmH T,)>,)*1(%; *.(

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    43/46

     

    [R

    BH?  m*(1'7., FH Q.21)($% QH Q')>'+)5$ AC A%,)'6),)(/ '+; =',);)(/ *9 ($% #$') =%15)*+ *9 ($% @W-?XC

    Z>- 3.,5?  r'+8 0FH t*+%5 A&C ]%+(%1 9*1 d>);%2)*,*8)< Q(.;)%5?h%>1%55)*+ Q*+5%5 '+;

    >1*:/?'55)5(%; 1%5>*+5%5 ;)99%1 91*2 I$'( F%;)?  ]$* WH u)2 PtC A')+5(',, FQH A.(,%;8% tAH N*1+5(%)+ mtH F'K.2;'1 FH P%5(1)'%*1(

    2%'5.1%2%+( %G.)=',%+%1?6'5%; >'()%+(?1%>*1(%; *.([8J "eJ"O)+ >1%55C

    CD?  Y8+)$*(1) uH YI'5($) QH Q)+8$ pH ]$'+;1' WH #$'7.1 QC Y 5(.;/ *9 1*:/ 1%>*1( *9 $%',($?1%,'(%; G.',)(/ *9 ,)9% )+ 51*:/ 1%>*1(C A*"'$#, %2 '$2/ +/./"+5< 7 "&

    $/+&"#$%&"' N%*+&"' %2 O*"'$#, %2 '$2/ ".:/5#. %2 #+/"#6/H 5"+/ "&1 +/1

    "ee`OJ[3R4UbR`?b[bC

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    44/46

     

    [[

    CG?  Z'1+) tPH m)26%15 ]YH N.1I)+7,% #FC @'1%+( >1*:/?1%>*1( *9 ($%)1 '1%+(5y 1%,)'6),)(/ '+; =',);)(/ '?  Q'8$%1) hH P)'(%1 YH Q(%99%+ @H BI%+5 tYC Y>>,/)+8 >1)+,%5 *9 8**; >1'('()*+ *9 5,%%>?5 Y1($1*>,'5(/ A%8)5(%1C 3"#$/I+/:%+#/1 4*#5%6/ >/".*+/. "&1 =/"'#)1* FH t*$+5(*+ hH P',; tH F*+ hC 3"#$/IK/&/+"#/1 =/"'#< ["#"J A#@H &]U A#V

    V+(%1+'()*+',O"eJ"CDD?  P. YPH Q+/;%1 ]C T%(()+8 1%';/ 9*1 >'()%+(?1%>*1(%; *.(1'

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    45/46

     

    [`

  • 8/20/2019 NQF PRO-Based Performance Measures for Accountable Healthcare Entities.pdf

    46/46

     

    Appendix A

    #$% Y2%1))+)*+ A%5%'1,%C #$% 1%>*1( >1*=);%5 5): ;%9)+)()*+5

    *9 1%5>*+5% 1'(%5H 1'+8)+8 91*2 ($% ;%9)+)()*+ ($'( /)%,;5 ($% ,*I%5( 1'(% (* ($%

    ;%9)+)()*+ ($'( /)%,;5 ($% $)8$%5( 1'(%H ;%>%+;)+8 *+ $*I >'1()', )+(%1=)%I5 '1%

    1*>*1()*+ *9 ',, *+;%+(

    1%9.5%5 (* 6% )+(%1=)%I%;H *1 61%'75?*99 '+ )+(%1=)%IH *9 ',, >*(%+()',,/ %,)8)6,%